Trials / Unknown
UnknownNCT04749979
Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin
Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin in IVF Cycles
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
Estradiol valerate in the form of cycloprogenova™ (white tablet only) was started on day 2 or 3 of cycle with oral dose 4 mg divided on 2 doses in addition to Aspocid 75 mg once daily with folic acid 500 mcg once daily.
Detailed description
U/S was done on day 9 or 10 of cycle to assess endometrial thickness, then every other day until endometrial thickness of 8 mm or more is reached and when endometrial thickness reaches 8 mm or more FET was planned. Progesterone in the form of prontogest™ 400 mg vaginal suppository twice dTwo to Four Day 5 Embryos was transferred
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Agonist (decapeptyl ) | giving agonist |
| DRUG | HCG ( eg. Choriomon ) | giving HCG |
Timeline
- Start date
- 2021-02-05
- Primary completion
- 2021-06-25
- Completion
- 2021-07-01
- First posted
- 2021-02-11
- Last updated
- 2021-02-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04749979. Inclusion in this directory is not an endorsement.